Search Results - "Lungulescu, D."

A randomized, double-blind, placebo-controlled phase II study to assess the efficacy and safety of mapatumumab with sorafenib in patients with advanced hepatocellular carcinoma by Ciuleanu, T., Bazin, I., Lungulescu, D., Miron, L., Bondarenko, I., Deptala, A., Rodriguez-Torres, M., Giantonio, B., Fox, N.L., Wissel, P., Egger, J., Ding, M., Kalyani, R.N., Humphreys, R., Gribbin, M., Sun, W.

“…This randomized, double-blind, placebo-controlled, phase II study evaluated the efficacy and safety of mapatumumab (a human agonistic monoclonal antibody…”
Get full text

A randomised double-blind placebo-controlled phase II study of AGI004 for control of chemotherapy-induced diarrhoea by Coyle, V M, Lungulescu, D, Toganel, C, Niculescu, A, Pop, S, Ciuleanu, T, Cebotaru, C, Devane, J, Martin, M, Wilson, R H

“…Background: AGI004 is a controlled-release transdermal patch preparation of mecamylamine. We conducted a randomised placebo-controlled phase II study of two…”
Get full text

Chemotherapy Related Severe Cardiac Dysfunction - Case Report by Cherata, D A, Cârstea, D, Zaharie, M, Bătăiosu, C, Lungulescu, D

“…Cardiotoxicity is the most important side effect of cancer therapy resulting in increased patient morbidity and mortality, therefore understanding its…”
Get full text

A randomised double-blind placebo-controlled phase II study of AG1004 for control of chemotherapy-induced diarrhoea by COYLE, V. M, LUNGULESCU, D, TOGANEL, C, NICULESCU, A, POP, S, CIULEANU, T, CEBOTARU, C, DEVANE, J, MARTIN, M, WILSON, R. H

Get full text